PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.35 +0.00 (+0.81%)
As of: Oct 22, 2026 · 3:07 PM EDT

PharmaCyte Biotech (PMCB) Acquisitions (2011 - 2013)

Updated

PharmaCyte Biotech's Acquisitions came in at $51,215 for FY2014 (year ended Apr 30, 2014).

Analysis

PharmaCyte Biotech (PMCB) Acquisitions (2011 - 2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,170.46 Bn 1,139.04 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 648.38 Bn 568.24 Bn 17.30 Bn -17.15 Bn
3 AbbVie 504.43 Bn 477.54 Bn 12.70 Bn -
4 Merck 367.73 Bn 322.11 Bn 12.21 Bn -
5 Novartis Ag 303.35 Bn 267.34 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 268.20 Bn 241.88 Bn 12.86 Bn -
7 Amgen 242.55 Bn 197.95 Bn 7.24 Bn -
8 Gilead Sciences 194.80 Bn 169.00 Bn 6.22 Bn 11.21 Bn
9 Pfizer 173.31 Bn 119.95 Bn 10.94 Bn -
10 PharmaCyte Biotech 3.72 Mn -69.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2013 -1.52 Mn
Jul 31, 2013 1.57 Mn
Apr 30, 2013 -481,750.00
Jan 31, 2013 160,000.00
Oct 31, 2012 126,000.00
Jul 31, 2012 195,750.00
Apr 30, 2012 194,230.00
Jan 31, 2012 120,000.00
Oct 31, 2011 240,000.00
Jul 31, 2011 320,000.00
API Access

PharmaCyte Biotech Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=PMCB&period=max&api_key=YOUR_API_KEY